Leading Edge Financial Planning »

Neurocrine Biosciences shares owned by Leading Edge Financial Planning

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Leading Edge Financial Planning from 13F filings

Historical chart of Leading Edge Financial Planning investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Leading Edge Financial Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Leading Edge Financial Planning

Quarter filed Position value Share count Share price at filing
2025-09-30 $227k 1.6k 140.38

More positions owned by Leading Edge Financial Planning

Spdr Series Trust Portfolio S&p500 (SPLG)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Us High Profitab (DUHP)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Spdr Series Trust Portfolio Agrgte (SPAB)
Dimensional Etf Trust Core Fixed Incom (DFCF)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Dimensional Etf Trust Inflation Prote (DFIP)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Ishares Tr Global Reit Etf (REET)
American Centy Etf Tr Real Estate Etf (AVRE)
Dimensional Etf Trust Ultrashort Fixed (DUSB)

View all positions for Leading Edge Financial Planning

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Dodge & Cox
Jpmorgan Chase & Co
State Street Corporation
AQR Capital Management
Renaissance Technologies
Geode Capital Management
Morgan Stanley
Wellington Management Company
Bellevue Group
Thomas Stevens, CFA"
Deerfield Management Company
Rtw Investments
Millennium Management

View all funds holding Neurocrine Biosciences